Literature DB >> 21304501

Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality.

Ziad F Gellad1, Karen M Stechuchak, Deborah A Fisher, Maren K Olsen, Jennifer R McDuffie, Truls Ostbye, William S Yancy.   

Abstract

OBJECTIVES: Existing cross-sectional quality measures for colorectal cancer (CRC) screening do not assess longitudinal adherence and thus may overestimate the quality of care. Our goal was to evaluate the adherence to repeated yearly fecal occult blood tests (FOBTs) in order to better understand the extent to which longitudinal adherence may impact screening quality.
METHODS: This was a retrospective cohort analysis of 1,122,645 patients aged 50-75 years seen at any of the 136 Department of Veterans Affairs medical centers across the United States in 2000 and followed through 2005. The primary outcome was receipt of adequate CRC screening as defined by receipt of FOBTs in at least 4 out of 5 years or receipt of any number of FOBTs in addition to at least one colonoscopy, flexible sigmoidoscopy, or double-contrast barium enema. In a predefined subset of patients receiving exclusively FOBT, adherence with repeated testing was determined over the 5-year study period.
RESULTS: Only 41.1% of men and 43.6% of women received adequate screening. Of the 384,527 men who received exclusively FOBT, 42.1% received a single FOBT, 26.0% received 2 tests, 17.8% received 3 tests, and only 14.1% were documented to have received at least 4 tests during the study period. Among the 10,469 female veterans receiving FOBT alone, rates were similar with only 13.7% completing at least 4 FOBTs in the 5-year study period.
CONCLUSIONS: Adherence to repeated FOBT is low, suggesting that cross-sectional measurements of quality may overestimate the programmatic success of CRC screening.

Entities:  

Mesh:

Year:  2011        PMID: 21304501     DOI: 10.1038/ajg.2011.11

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  36 in total

Review 1.  Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.

Authors:  Jeffrey K Lee; Elizabeth G Liles; Stephen Bent; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

2.  Third Annual Fecal Occult Blood Testing in Community Health Clinics.

Authors:  Connie L Arnold; Alfred Rademaker; Michael S Wolf; Dachao Liu; Jill Hancock; Terry C Davis
Journal:  Am J Health Behav       Date:  2016-05

3.  Changes in Colorectal Cancer Screening Knowledge, Behavior, Beliefs, Self-Efficacy, and Barriers among Community Health Clinic Patients after a Health Literacy Intervention.

Authors:  Connie L Arnold; Alfred Rademaker; Dachao Liu; Terry C Davis
Journal:  J Community Med Health Educ       Date:  2017-01-13

Review 4.  Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines.

Authors:  Barry M Berger; Bernard Levin; Robert J Hilsden
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

5.  Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.

Authors:  Caitlin C Murphy; Robert S Sandler; Hanna K Sanoff; Y Claire Yang; Jennifer L Lund; John A Baron
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-05       Impact factor: 11.382

6.  Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.

Authors:  Ulrike Haug; Amy B Knudsen; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  Int J Cancer       Date:  2014-12-03       Impact factor: 7.396

7.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

Review 8.  New era of colorectal cancer screening.

Authors:  Maysaa El Zoghbi; Linda C Cummings
Journal:  World J Gastrointest Endosc       Date:  2016-03-10

9.  Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.

Authors:  Caitlin C Murphy; Sally W Vernon; Nicole M Haddock; Melissa L Anderson; Jessica Chubak; Beverly B Green
Journal:  Prev Med       Date:  2014-06-15       Impact factor: 4.018

10.  Strategies to improve repeat fecal occult blood testing cancer screening.

Authors:  Terry C Davis; Connie L Arnold; Charles L Bennett; Michael S Wolf; Cristalyn Reynolds; Dachao Liu; Alfred Rademaker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-05       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.